Derek Crowther

3.5k total citations
55 papers, 1.4k citations indexed

About

Derek Crowther is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Derek Crowther has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 13 papers in Immunology. Recurrent topics in Derek Crowther's work include Lymphoma Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Derek Crowther is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Derek Crowther collaborates with scholars based in United Kingdom, United States and Netherlands. Derek Crowther's co-authors include Joseph L. Melnick, Nick Thatcher, Peter Maguire, Nicholas Thatcher, G. Blackledge, John Wagstaff, J.H. Scarffe, Michael K. Palmer, R. Swindell and Charles B. Pratt and has published in prestigious journals such as Science, Cancer and British Journal of Cancer.

In The Last Decade

Derek Crowther

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek Crowther United Kingdom 21 592 376 280 210 185 55 1.4k
L.M. Jost Switzerland 20 651 1.1× 226 0.6× 218 0.8× 157 0.7× 506 2.7× 39 1.6k
David M. Mintzer United States 22 545 0.9× 173 0.5× 439 1.6× 402 1.9× 477 2.6× 60 2.3k
W. H. Churchill United States 22 236 0.4× 229 0.6× 130 0.5× 253 1.2× 95 0.5× 34 1.8k
Daniel E. Lehane United States 21 596 1.0× 98 0.3× 195 0.7× 221 1.1× 277 1.5× 51 1.6k
Lucien Israël France 23 697 1.2× 131 0.3× 341 1.2× 283 1.3× 260 1.4× 107 1.5k
John C. Marsh United States 25 526 0.9× 107 0.3× 646 2.3× 273 1.3× 233 1.3× 65 2.1k
Eric L. Jenison United States 18 578 1.0× 307 0.8× 574 2.0× 417 2.0× 176 1.0× 37 2.6k
Jeffrey L. Berenberg United States 19 829 1.4× 188 0.5× 191 0.7× 207 1.0× 341 1.8× 63 1.7k
Maria Moschovi Greece 23 427 0.7× 149 0.4× 633 2.3× 117 0.6× 219 1.2× 104 1.9k
Soji F. Oluwole United States 24 592 1.0× 214 0.6× 208 0.7× 746 3.6× 123 0.7× 127 2.2k

Countries citing papers authored by Derek Crowther

Since Specialization
Citations

This map shows the geographic impact of Derek Crowther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Crowther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Crowther more than expected).

Fields of papers citing papers by Derek Crowther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Crowther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Crowther. The network helps show where Derek Crowther may publish in the future.

Co-authorship network of co-authors of Derek Crowther

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Crowther. A scholar is included among the top collaborators of Derek Crowther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Crowther. Derek Crowther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cowan, Richard, Brian Murby, S. E. Owens, et al.. (2002). Autologous lymphocytes as vectors to target therapeutic radiation, using indium‐114m, in patients with lymphoid cell malignancy. British Journal of Haematology. 119(2). 459–466. 5 indexed citations
2.
McGown, Alan T., et al.. (1998). High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction technique. Journal of Chromatography B Biomedical Sciences and Applications. 709(1). 113–117. 9 indexed citations
3.
Keizer, H.J., et al.. (1997). EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma. Sarcoma. 1(2). 99–101. 9 indexed citations
4.
Taylor, G. Malcolm, David Gokhale, Derek Crowther, et al.. (1996). Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated.. PubMed. 10(5). 854–9. 25 indexed citations
5.
Lee, Siow Ming, Martin Harris, Alan T. McGown, et al.. (1993). Expression of O6-alkylguanine-DNA-alkyltransferase in situ in ovarian and Hodgkin's tumours. European Journal of Cancer. 29(9). 1306–1312. 22 indexed citations
6.
Lord, Brian I., Howard Gurney, James Chang, et al.. (1992). Haemopoietic cell kinetics in humans treated with rGM‐CSF. International Journal of Cancer. 50(1). 26–31. 43 indexed citations
7.
Lee, Siow Ming, et al.. (1992). In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue. Cancer Chemotherapy and Pharmacology. 31(3). 240–246. 15 indexed citations
8.
Burden, A. David, Beryl Oppenheim, Derek Crowther, et al.. (1991). Viridans streptococcal bacteraemia in patients with haematological and solid malignancies. European Journal of Cancer and Clinical Oncology. 27(4). 409–411. 45 indexed citations
9.
Price, C. G. A., A. Z. S. Rohatiner, William P. Steward, et al.. (1991). Interferon alfa-2b in addition to chlorambucil in the treatment of follicular lymphoma: Preliminary results of a randomized trial in progress. European Journal of Cancer and Clinical Oncology. 27. S34–S36. 12 indexed citations
10.
Lister, T. Andrew & Derek Crowther. (1990). Staging for hodgkins-disease.. Seminars in Oncology. 1 indexed citations
11.
Maguire, Peter, et al.. (1989). The recognition of psychiatric morbidity on a medical oncology ward. Journal of Psychosomatic Research. 33(2). 235–239. 148 indexed citations
12.
Lind, Michael, et al.. (1989). The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochemical Pharmacology. 38(11). 1835–1840. 74 indexed citations
13.
Wagstaff, John, et al.. (1987). A phase I study of recombinant interferon gamma administered by s.c. injection three times per week in patients with solid tumours. Cancer Immunology Immunotherapy. 25(1). 54–8. 16 indexed citations
14.
Wong, Wai‐Man, V. R. Tindall, John Wagstaff, Vivien Bramwell, & Derek Crowther. (1985). Surgery and Radiotherapy in the Treatment of Primary Carcinoma of the Fallopian Tube – Report of 18 Cases. Australian and New Zealand Journal of Obstetrics and Gynaecology. 25(3). 211–215. 2 indexed citations
15.
Wagstaff, John, et al.. (1982). The “Hot spleen” phenomenon in metastatic malignant melanoma. Its incidence and relationship with the immune system. Cancer. 49(3). 439–444. 6 indexed citations
16.
Thatcher, Nick, et al.. (1981). Effects ofCorynebacterium parvum on cellular immunity of cancer patients, assayed sequentially over 63 days. Cancer. 47(2). 285–290. 7 indexed citations
17.
Wagstaff, John, Crystal Gibson, Nick Thatcher, et al.. (1981). A method for following human lymphocyte traffic using indium-111 oxine labelling.. PubMed. 43(3). 435–42. 51 indexed citations
18.
19.
Thatcher, Nick, R. Swindell, & Derek Crowther. (1979). Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.. PubMed Central. 35(2). 171–9. 15 indexed citations
20.
Blackledge, G., et al.. (1979). Role of Computed Tomography in Staging and Management of Gastrointestinal Lymphoma. Journal of the Royal Society of Medicine. 72(11). 818–822. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L.M. Jost Breakdown of academic impact, for papers by David M. Mintzer Breakdown of academic impact, for papers by W. H. Churchill Breakdown of academic impact, for papers by Daniel E. Lehane Breakdown of academic impact, for papers by Lucien Israël Breakdown of academic impact, for papers by John C. Marsh Breakdown of academic impact, for papers by Eric L. Jenison Breakdown of academic impact, for papers by Jeffrey L. Berenberg Breakdown of academic impact, for papers by Maria Moschovi Breakdown of academic impact, for papers by Soji F. Oluwole
Rankless by CCL
2026